Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 817 across all filing types
Latest filing 2020-07-10 Transaction in Own Shar…
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Informativa settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE DELLA DIASORIN S.P.A." (Weekly Information on the Share Buyback Program of DiaSorin S.p.A.). It details the number of shares purchased by the company itself (n. 17.000 azioni proprie) during the period of July 6, 2020, to July 10, 2020. This directly corresponds to the definition of a report concerning the company buying back or selling its own shares. Therefore, the correct classification is Transaction in Own Shares (POS).
2020-07-10 Italian
Notice availability Shareholders' meeting minutes June 10, 2020
Report Publication Announcement Classification · 98% confidence The document is a formal notification from DiaSorin S.p.A. dated July 10, 2020. The subject line explicitly states: 'Notice availability Shareholders' meeting minutes June 10, 2020'. The body confirms that the minutes of the Ordinary Shareholders' Meeting have been made available to the public at various locations, including the company website and storage mechanism. Since this document is an announcement about the availability of the minutes (the actual report), and not the minutes themselves, it fits the definition of a Report Publication Announcement (RPA). The document length (1878 chars) is short, supporting the 'MENU VS MEAL' rule.
2020-07-10 English
Avviso disponibilita' verbale Assemblea degli Azionisti 10 giugno 2020
Report Publication Announcement Classification · 98% confidence The document is a formal notice from DiaSorin S.p.A. dated July 10, 2020. The subject ('Oggetto') is 'Avviso disponibilita' verbale Assemblea degli Azionisti 10 giugno 2020' (Notice of availability of the minutes of the Shareholders' Meeting of June 10, 2020). The text explicitly states that the minutes ('verbale') of the Shareholders' Meeting are now available to the public at various locations, including the company website. This structure—a short announcement stating that a formal document (the meeting minutes) is now available—fits the definition of a Report Publication Announcement (RPA). It is not the minutes themselves, but the notice of their availability.
2020-07-10 Italian
Verbale Assemblea degli Azionisti 10 giugno 2020
AGM Information
2020-07-10 Italian
DiaSorin will provide the UK Government with its LIAISON SARS-CoV-2 S1/S2 IgG serology kit for COVID-19 testing to run a national screening study
Regulatory Filings Classification · 95% confidence The document is a formal announcement dated July 9, 2020, detailing a significant business event: DiaSorin providing its SARS-CoV-2 serology kit to the UK Government for a national screening study. The metadata indicates the filing type is 'REGEM' (Regulated Information) and the subject is a commercial/operational update regarding a contract/supply agreement. This type of announcement, which details a major business development, contract win, or significant operational milestone that is not a standard periodic financial report (like 10-K or IR) or a specific corporate action (like DIV or SHA), fits best under the general category for regulatory announcements that don't have a more specific code. Since it is a formal regulatory disclosure ('Informazione Regolamentata'), and it doesn't fit ER, CT, CAP, or LTR, the most appropriate general category for significant, non-standard regulatory news is RNS (Regulatory Filings/General Regulatory Announcements). It is not a presentation (IP), a management change (MANG), or a financing event (CAP).
2020-07-09 English
DiaSorin fornirà al Regno Unito il test sierologico LIAISON SARS-CoV-2 S1/S2 IgG per il completamento di uno screening della popolazione
Environmental & Social Information Classification · 99% confidence The document is an official communication from DiaSorin, identified by the metadata fields ('Informazione Regolamentata', 'Tipologia: REGEM') and the subject line ('Oggetto'). The content announces a specific business event: the selection of their SARS-CoV-2 IgG test by the UK's NHS England for population screening. This is a material, non-periodic business update concerning a significant contract/product deployment. It is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a proxy statement (DEF 14A). Since it is a specific, material announcement that doesn't fit the other specialized categories (like M&A, Capital Change, Dividend), it falls best under the general 'Regulatory Filings' category (RNS), which serves as a catch-all for significant, non-standard regulatory disclosures, especially those originating from European regulated markets (like Borsa Italiana, indicated by the MTA tag and Italian language). The document length is moderate, but the content is purely informational about a contract/product adoption, not an announcement *of* a report.
2020-07-09 Italian

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.